NextAR TKA Platform— 510(k) K193559

Substantially Equivalent

Medacta Inernational SA

FDA 510(k) clearance K193559 for NextAR TKA Platform, Substantially Equivalent on 2020-07-10. Applicant: Medacta Inernational SA.

Clearance details

Applicant: Medacta Inernational SA
Product code: Code SBF
Advisory panel: Neurology
Date received: 2019-12-23
Decision date: 2020-07-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Castel San Pietro (Ch), CH

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.